medigraphic.com
ISSN 1405-1699 (Impreso)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2019, Número 1

<< Anterior

Alerg Asma Inmunol Pediatr 2019; 28 (1)


Vitamina D y su papel en el sistema inmune

Ramírez SE, Pedroza MÁ

Idioma: Español
Referencias bibliográficas: 41
Paginas: 26-34
Archivo PDF: 224.88 Kb.


RESUMEN

Al ser catalogada como una vitamina y clasificarse como un nutrimento dispensable, se dejó su función por un tiempo limitada al metabolismo óseo y sus enfermedades asociadas con ese nivel, sin embargo, con el tiempo fueron describiéndose a principios de este siglo la actividad genómica en la que estaba relacionada la vitamina D, así como los efectos directos y rápidos que causaba a nivel molecular, modificándose respuestas celulares en diferentes ámbitos y en diversos pasos metabólicos, por lo que se observó su efecto como contexto a nivel celular y ahora como causa de enfermedad como tal, por lo que ha motivado su estudio en diferentes enfermedades a diferentes órganos y sistemas, por lo que ahora se hace una revisión de su función sobre la salud y la enfermedad en el sistema inmune. Y además describimos lo difícil de obtener de la ingesta diaria, así como describir las dosis más actuales recomendadas en su deficiencia y en la enfermedad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kaufer-Horwitz M, Pérez-Lizaur AB, Arroyo P. Nutriología médica. Capítulo 3. 4a edición. Ed. Panamericana; 2015. pp. 40-60.

  2. Holick MF, MacLaughlin JA, Clark MB, Holick SA, Potts JT Jr, Anderson RR et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science. 1980; 210 (4466): 203-205.

  3. Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. Endocrinol Metab Clin North Am. 2010; 39 (2): 243-253.

  4. Morris HA, Anderson PH. Autocrine and paracrine actions of vitamin D. Clin Biochem Rev. 2010; 31 (1): 129-138.

  5. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009; 94 (1): 26-34.

  6. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008; 88 (2): 491S-499S.

  7. Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am. 2010; 39 (2): 255-269.

  8. Mizwicki MT, Norma AW. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Sci Signal. 2009; 2 (75): re4.

  9. Trochoutsou AI, Kloukina V, Samitas K, Xanthou G. Vitamin-D in the immune system: genomic and non-genomic actions. Mini Rev Med Chem. 2015; 15 (11): 953-963.

  10. Liu PT, Stenger S, Li H, Wenzel L et al. Toll like receptor triggering of a vitamin D-mediated human antimicrobial responce. Science. 2006; 311 (5768): 1770-1773.

  11. Castrillo RL, Palma RA, Padilla DC. Péptidos antimicrobianos: antibióticos naturales de la piel. Dermatología Rev Mex. 2007; 51 (2): 57-67.

  12. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005; 19 (9): 1067-1077.

  13. Bouvard B, Annweiler C, Sallé A, Beauchet O, Chappard D, Audran M et al. Extraskeletal effects of vitamin D: facts, uncertainties, and controversies. Joint Bone Spine. 2011; 78 (1): 10-16.

  14. Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012; 188 (5): 2127-2135.

  15. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am. 2010; 39 (2): 365-379.

  16. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M et al. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol. 2010; 30 (12): 2495-2503.

  17. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol. 2004; 215 (1-2): 31-38.

  18. Matsui T, Nakao Y, Koizumi T, Nakagawa T, Fujita T. 1,25- Dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets. Life Sci. 1985; 37: 95-101.

  19. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001; 167 (9): 4974-4980.

  20. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther. 2008; 324 (1): 23-33.

  21. Cantorna MT, Hullett DA, Redaelli C, Brandt CR, Humpal-Winter J, Sollinger HW et al. 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation. 1998; 66 (7): 828-831.

  22. Merrill SJ, Minucci SB. Thyroid Autoimmunity: an interplay of factors. Vitam Horm. 2018; 106: 129-145.

  23. Bagot M, Charue D, Lescs MC, Pamphile RP, Revuz J. Immunosuppressive effects of 1,25-dihydroxyvitamin D3 and its analogue calcipotriol on epidermal cells. Br J Dermatol. 1994; 130 (4): 424-431.

  24. Khosravi-Largani M, Pourvali-Talatappeh P, Rousta AM, Karimi-Kivi M, Noroozi E, Mahjoob A et al. A review on potential roles of vitamins in incidence, progression, and improvement of multiple sclerosis. eNeurologicalSci. 2018; 10: 37-44.

  25. Vasquez AD. La vitamina D y su importancia en la salud humana. Medicina. 2013; 35 (3): 214-226.

  26. Zuluaga ENA, Alfaro VJM, Balthazar GV, Jiménez BKE, Campuzano MG. Vitamina D: nuevos paradigmas. Medicina & Laboratorio. 2011; 17 (05-06): 211-246.

  27. Correale J, Ysrraelit MC, Gaitán MI. Efectos inmunomoduladores de la vitamina d en esclerosis múltiple. Neurología Argentina. 2009; 1 (2): 82-94.

  28. Paul G, Brehm JM, Alcorn JF, Holguín F, Aujla SJ, Celedón JC. Vitamin D and asthma. Am J Respir Crit Care Med. 2012; 185 (2): 124-132.

  29. Demir MG. Comparison of 1α-25-dihydroxyvitamin D3 and IgE levels between allergic rhinitis patients and healthy people. Int Arch Otorhinolaryngol. 2018; 22 (4): 428-431.

  30. Sadat-Ali M, Al-Anii FM, Al-Turki HA, AlBadran AA, AlShammari SM. Maintenance dose of vitamin d: how much is enough? J Bone Metab. 2018; 25 (3): 161-164.

  31. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357 (3): 266-281.

  32. Diehl JW, Chiu MW. Effects of ambient sunlight and photoprotection on vitamin D status. Dermatol Ther. 2010; 23 (1): 48-60.

  33. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008; 122 (2): 398-417.

  34. Boskabadi H, Zakerihamidi M, Faramarzi R. The vitamin D level in umbilical cord blood in premature infants with or without intra-ventricular hemorrhage: A cross-sectional study. Int J Reprod Biomed (Yazd). 2018; 16 (7): 429-434.

  35. Grossman Z, Hadjipanayis A, Stiris T, Del Torso S, Mercier JC, Valiulis A et al. Vitamin D in European children-statement from the European Academy of Paediatrics (EAP). Eur J Pediatr. 2017; 176 (6): 829-831.

  36. Ongaratto R, Rosa KMD, Eloi JC, Epifanio M, Marostica P, Pinto LA. Association between hypovitaminosis D and frequency of pulmonary exacerbations in children and adolescents with cystic fibrosis. Einstein (Sao Paulo). 2018; 16 (1): eAO4143.

  37. Weiler H, Fitzpatrick-Wong S, Veitch R, Kovacs H, Schellenberg J, McCloy U et al. Vitamin D deficiency and whole-body and femur bone mass relative to weight in healthy newborns. CMAJ. 2005; 172 (6): 757-761.

  38. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96 (7): 1911-1930.

  39. Farraye FA, Nimitphong H, Stucchi A, Dendrinos K, Boulanger AB, Vijjeswarapu A et al. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn’s disease. Inflamm Bowel Dis. 2011; 17 (10): 2116-2121.

  40. Pramyothin P, Holick MF. Vitamin D supplementation: guidelines and evidence for subclinical deficiency. Curr Opin Gastroenterol. 2012; 28 (2): 139-150.

  41. Mendoza-Zubieta V, Reza-Albarrán AA. Vitamina D: Más allá del tratamiento de las enfermedades óseas. Rev Endocrinol Nutr. 2009; 17 (1): 4-6.




2020     |     www.medigraphic.com